Please use this identifier to cite or link to this item:
http://hdl.handle.net/10397/79808
| Title: | Modified penicillin molecule with carbapenem- like stereochemistry specifically inhibits class C beta-lactamases | Authors: | Pan, XH He, YJ Chen, TF Chan, KF Zhao, YX |
Issue Date: | Dec-2017 | Source: | Antimicrobial agents and chemotherapy, Dec. 2017, v. 61, no. 12, e01288-17 | Abstract: | Bacterial beta-actamases readily inactivate most penicillins and cephalosporins by hydrolyzing and "opening" their signature beta-lactam ring. In contrast, carbapenems resist hydrolysis by many serine-based class A, C, and D beta-lactamases due to their unique stereochemical features. To improve the resistance profile of penicillins, we synthesized a modified penicillin molecule, MPC-1, by "grafting" carbapenem-like stereochemistry onto the penicillin core. Chemical modifications include the trans conformation of hydrogen atoms at C-5 and C-6 instead of cis, and a 6-alpha hydroxyethyl moiety to replace the original 6-beta aminoacyl group. MPC-1 selectively inhibits class C beta-lactamases, such as P99, by forming a nonhydrolyzable acyl adduct, and its inhibitory potency is similar to 2 to 5 times higher than that for clinically used beta-lactamase inhibitors clavulanate and sulbactam. The crystal structure of MPC-1 forming the acyl adduct with P99 reveals a novel binding mode for MPC-1 that resembles carbapenem bound in the active site of class A beta-lactamases. Furthermore, in this novel binding mode, the carboxyl group of MPC-1 blocks the deacylation reaction by occluding the critical catalytic water molecule and renders the acyl adduct nonhydrolyzable. Our results suggest that by incorporating carbapenem-like stereochemistry, the current collection of over 100 penicillins and cephalosporins can be modified into candidate compounds for development of novel beta-lactamase inhibitors. | Keywords: | Beta-lactamase inhibitor Carbapenem-like Class C beta-lactamase |
Publisher: | American Society for Microbiology | Journal: | Antimicrobial agents and chemotherapy | ISSN: | 0066-4804 | EISSN: | 1098-6596 | DOI: | 10.1128/AAC.01288-17 | Rights: | © 2017 American Society for Microbiology. All Rights Reserved. |
| Appears in Collections: | Journal/Magazine Article |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| AAC.01288-17.pdf | 2.37 MB | Adobe PDF | View/Open |
Access
View full-text via PolyU eLinks 
Page views
48
Last Week
1
1
Last month
Citations as of Jun 4, 2023
Downloads
14
Citations as of Jun 4, 2023
SCOPUSTM
Citations
5
Citations as of Jun 2, 2023
WEB OF SCIENCETM
Citations
5
Last Week
0
0
Last month
Citations as of Jun 1, 2023
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.